NEW YORK (GenomeWeb News) – Waters today reported that its revenues in the second quarter were flat year over year, as it experienced a late-quarter slowdown in instrument systems orders.

The company posted Q2 revenues of $451 million, short of the average Wall Street estimate of $466.4 million. It reported a profit of $89.3 million, or $1.03 per share, during the quarter, compared to a profit of $97.7 million, or $1.09 per share, a year ago.

On a non-GAAP basis, Waters had EPS of $1.08, below the average analyst estimate of $1.21.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.